5-benzyl-7,7-dimethyl-2-(phenoxymethyl)-6H-pyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-[(3-methylphenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-chlorophenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylbenzimidazol-2-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methyl-2-pyridinyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
C165H163ClN28O16S — CID 158426392
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-benzyl-7,7-dimethyl-2-(phenoxymethyl)-6H-pyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-[(3-methylphenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-chlorophenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylbenzimidazol-2-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methyl-2-pyridinyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
5-benzyl-7,7-dimethyl-2-(phenoxymethyl)-6H-pyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-[(3-methylphenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-chlorophenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylbenzimidazol-2-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methyl-2-pyridinyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one (PubChem CID 158426392) has the molecular formula C165H163ClN28O16S and a molecular weight of 2861.82 g/mol. Its IUPAC name is 5-benzyl-7,7-dimethyl-2-(phenoxymethyl)-6H-pyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-[(3-methylphenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-chlorophenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylbenzimidazol-2-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methyl-2-pyridinyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one.
Molecular Properties
| Compound Name | 5-benzyl-7,7-dimethyl-2-(phenoxymethyl)-6H-pyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-[(3-methylphenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-chlorophenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylbenzimidazol-2-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methyl-2-pyridinyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one |
|---|---|
| PubChem CID | 158426392 |
| Molecular Formula | C165H163ClN28O16S |
| Molecular Weight | 2861.82 g/mol |
| Exact Mass | 2859.22 |
| IUPAC Name | 5-benzyl-7,7-dimethyl-2-(phenoxymethyl)-6H-pyrazolo[1,5-a]pyrazin-4-one;5-benzyl-2-[(3-methylphenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-chlorophenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(1-methylbenzimidazol-2-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methylphenyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(3-methyl-2-pyridinyl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one |
| SMILES | CC1(C)CN(Cc2ccccc2)C(=O)c2cc(COc3ccccc3)nn21.Cc1cccc(CN2CCn3nc(COc4ccccc4)cc3C2=O)c1.Cc1cccc(OCc2cc3n(n2)CCN(Cc2ccccc2)C3=O)c1.Cc1ccccc1CN1CCn2nc(COc3ccccc3)cc2C1=O.Cc1cccnc1CN1CCn2nc(COc3ccccc3)cc2C1=O.Cc1nc(CN2CCn3nc(COc4ccccc4)cc3C2=O)cs1.Cn1c(CN2CCn3nc(COc4ccccc4)cc3C2=O)nc2ccccc21.O=C1c2cc(COc3ccccc3)nn2CCN1Cc1ccccc1Cl |
| InChI | InChI=1S/C22H21N5O2.C22H23N3O2.3C21H21N3O2.C20H18ClN3O2.C20H20N4O2.C18H18N4O2S/c1-25-19-10-6-5-9-18(19)23-21(25)14-26-11-12-27-20(22(26)28)13-16(24-27)15-29-17-7-3-2-4-8-17;1-22(2)16-24(14-17-9-5-3-6-10-17)21(26)20-13-18(23-25(20)22)15-27-19-11-7-4-8-12-19;1-16-7-5-6-8-17(16)14-23-11-12-24-20(21(23)25)13-18(22-24)15-26-19-9-3-2-4-10-19;1-16-6-5-7-17(12-16)14-23-10-11-24-20(21(23)25)13-18(22-24)15-26-19-8-3-2-4-9-19;1-16-6-5-9-19(12-16)26-15-18-13-20-21(25)23(10-11-24(20)22-18)14-17-7-3-2-4-8-17;21-18-9-5-4-6-15(18)13-23-10-11-24-19(20(23)25)12-16(22-24)14-26-17-7-2-1-3-8-17;1-15-6-5-9-21-18(15)13-23-10-11-24-19(20(23)25)12-16(22-24)14-26-17-7-3-2-4-8-17;1-13-19-15(12-25-13)10-21-7-8-22-17(18(21)23)9-14(20-22)11-24-16-5-3-2-4-6-16/h2-10,13H,11-12,14-15H2,1H3;3-13H,14-16H2,1-2H3;2-10,13H,11-12,14-15H2,1H3;2*2-9,12-13H,10-11,14-15H2,1H3;1-9,12H,10-11,13-14H2;2-9,12H,10-11,13-14H2,1H3;2-6,9,12H,7-8,10-11H2,1H3 |
| InChIKey | HBCGBQUYDUKMPC-UHFFFAOYSA-N |
| XLogP | 26.61 |
| TPSA | 422.48 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 40 |
| Heavy Atoms | 211 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2861.82 |
| LogP ≤ 5 | 26.61 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 37 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158426392 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.